Michael R Olin

20042021

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

CD200 checkpoint reversal: A novel approach to immunotherapy a C

Xiong, Z., Mesias, E. A., Elizabeth Pluhar, G., Rathe, S. K., Largaespada, D. A., Sham, Y. Y., Moertel, C. L. & Olin, M. R., Jan 1 2020, In : Clinical Cancer Research. 26, 1, p. 232-241 10 p.

Research output: Contribution to journalArticle

Open Access
  • Open Access
  • 4 Scopus citations

    Tumor-derived exosomes, microRNAs, and cancer immune suppression

    Graner, M. W., Schnell, S. & Olin, M. R., Sep 1 2018, In : Seminars in Immunopathology. 40, 5, p. 505-515 11 p.

    Research output: Contribution to journalReview article

    Open Access
  • 20 Scopus citations
    Open Access
  • 13 Scopus citations

    Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant

    Andersen, B. M., Xia, J., Epstein, A. L., Ohlfest, J. R., Chen, W., Blazar, B. R., Pennell, C. A. & Olin, M. R., Feb 16 2016, In : Journal for ImmunoTherapy of Cancer. 4, 1, 11.

    Research output: Contribution to journalArticle

  • 9 Scopus citations